66
|
286
|
7m5zA |
Crystal structure of the mertk kinase domain in complex with inhibitor mips15692 |
0
|
16
|
6vxgA |
Structure of the c-terminal domain of rage and its inhibitor |
0
|
15
|
6wgnE |
Crystal structure of k-ras(g12d) gppnhp bound to cyclic peptide ligand kd2 |
64
|
169
|
6wgnA |
Crystal structure of k-ras(g12d) gppnhp bound to cyclic peptide ligand kd2 |
98
|
297
|
6juxA |
Crystal structure of human alk2 kinase domain with r206h mutation in complex with rk-71807 |
60
|
169
|
6p0iB |
Crystal structure of gdp-bound human rala in a covalent complex with aryl sulfonyl fluoride compounds. |
61
|
168
|
6p0kB |
Crystal structure of gdp-bound human rala in a covalent complex with aryl sulfonyl fluoride compounds. |
61
|
168
|
6p0mB |
Crystal structure of gdp-bound human rala in a covalent complex with aryl sulfonyl fluoride compounds. |
59
|
168
|
6p0nB |
Crystal structure of gdp-bound human rala in a covalent complex with aryl sulfonyl fluoride compounds. |
61
|
168
|
6p0lB |
Crystal structure of gdp-bound human rala in a covalent complex with aryl sulfonyl fluoride compounds. |
44
|
125
|
6jj5A |
Brd4 in complex with 259 |
43
|
125
|
6jj6A |
Brd4 in complex with 500 |
41
|
125
|
6jjbA |
Brd4 in complex with zzm1 |
44
|
125
|
6jj3A |
Brd4 in complex with 138a |
63
|
169
|
6pgpA |
Crystal structure of human kras g12c covalently bound to a quinazolinone inhibitor |
55
|
167
|
6pgoA |
Crystal structure of human kras g12c covalently bound to a phthalazine inhibitor |
137
|
396
|
6nfaA |
Vav1 inhibited by an allosteric inhibitor: vav1 inhibitors block gef activity |
53
|
169
|
6v5lA |
The haddock structure model of gdp kras in complex with its allosteric inhibitor e22 |
102
|
296
|
6uyaA |
Crystal structure of compound 19 bound to irak4 |
87
|
1063
|
6nzdI |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
34
|
121
|
6nzdC |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
19
|
109
|
6nzdA |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
107
|
557
|
6nzdH |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
24
|
91
|
6nzdE |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
60
|
286
|
6nzdF |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
18
|
90
|
6nzdD |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
33
|
126
|
6nzdB |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
83
|
306
|
6nzdG |
Cryo-em structure of the lysosomal folliculin complex (flcn-fnip2-raga-ragc-ragulator) |
81
|
279
|
6pdjA |
Tyrosine-protein kinase lck bound to compound 11 |
13
|
81
|
6ak2A |
Crystal structure of the syntenin pdz1 domain in complex with the peptide inhibitor ksl-128018 |
57
|
166
|
6p8yA |
Crystal structure of human kras g12c covalently bound to an acryloylazetidine acetamide inhibitor. |
58
|
169
|
6p8wA |
Crystal structure of human kras g12c covalently bound to an acryloylazetidine acetamide inhibitor. |
61
|
169
|
6p8zA |
Crystal structure of human kras g12c covalently bound to an acryloylazetidine acetamide inhibitor |
58
|
166
|
6p8xA |
Crystal structure of human kras g12c covalently bound to an acryloylazetidine acetamide inhibitor. |
42
|
127
|
6afrA |
Crystal structure of the first bromodomain of human brd4 in complex with 5-((4-fluoro-1h-imidazol-1-yl)methyl)quinolin-8-ol |
76
|
287
|
6ocqA |
Crystal structure of rip1 kinase in complex with a pyrrolidine |
44
|
127
|
3u5jA |
Crystal structure of the first bromodomain of human brd4 in complex with alprazolam |
0
|
6
|
5h10D |
Traf1-tank complex |
93
|
270
|
6e4fA |
Crystal structure of arq 531 in complex with the kinase domain of btk |
169
|
517
|
6dm8A |
Understanding the species selectivity of myeloid cell leukemia-1 (mcl-1) inhibitors |
60
|
150
|
6b4lA |
Crystal structure of mcl-1 in complex with a bim competitive inhibitor |
58
|
155
|
6b4uA |
Crystal structure of mcl-1 in complex with a bim competitive inhibitor |
61
|
170
|
6arkA |
Crystal structure of compound 10 covalently bound to k-ras g12c |
40
|
108
|
5uvxA |
Brd4 bromodomain 2 with a-1359643 |
41
|
109
|
5uvsA |
Brd4_bd2_a-1406537 |
40
|
109
|
5uvzA |
Brd4 bromodomain 2 with a-1354689 |
25
|
83
|
5vk1A |
Crystal structure of human mdm4 in complex with a 12-mer lysine-cysteine side chain dithiocarbamate stapled peptide inhibitor pmi |
43
|
131
|
5cy9A |
Crystal structure of the first bromodomain of human brd4 in complex with benzo[cd]indol-2(1h)-one ligand |
41
|
129
|
5d0cA |
Crystal structure of the first bromodomain of human brd4 in complex with benzo[cd]indol-2(1h)-one ligand |
41
|
132
|
5coiA |
Crystal structure of the first bromodomain of human brd4 in complex with benzo[cd]indol-2(1h)-one ligand |